熱門資訊> 正文
ING、Pali和FNCH均为上市前输家
2024-04-24 20:45
- Losers: Evotec SE (EVO) -31% reports FY results
- Finch Therapeutics Group (FNCH) -14%.
- NKGen Biotech (NKGN) -14%.
- HWH International (HWH) -13%.
- Neo-Concept International Group Holdings Ltd. (NCI) -12%.
- SILO Pharma (SILO) -9%.
- AGBA Group Holding Limited (AGBA) -9%.
- Equinox Gold Corp (EQX) -8% buys rest of Greenstone gold mine in $995M cash and stock deal.
- Enphase Energy (ENPH) -7% after Q1 earnings release.
- ING Groep N.V. (ING) -6%.
- Zhongchao (ZCMD) -6%.
- Cazoo Group Ltd (CZOO) -6%.
- Palisade Bio (PALI) -5%.
More on pre-market losers & stocks.
- ING: Still Too Cheap Despite Disappointing Results
- ING Groep NV (ING) Q4 2023 Earnings Call Transcript
- Palisade Bio stock rallies nearly 100% on colitis drug analysis
- Palisade Bio stock slides 8% amid colitis drug presentation
- Financial information for Finch Therapeutics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。